Dyne Therapeutics, Inc. (DYN) Earnings History
Net Loss19 years of earnings data (2007–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Dyne Therapeutics, Inc. (DYN) Earnings Overview
As of November 7, 2026, Dyne Therapeutics, Inc. (DYN) reported trailing twelve-month net income of -$605M, reflecting -3.0% year-over-year growth. The company earned $-3.33 per diluted share over the past four quarters.
Looking at the long-term picture, DYN's historical earnings data spans multiple years. The company achieved its highest annual net income of $264M in fiscal 2007.
Dyne Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SRPT ($15M net income, -32.5% margin), CRSP (-$456M net income, -16569.8% margin), BMRN (-$19M net income, 10.8% margin), DYN has comparable earnings metrics. Compare DYN vs SRPT →
DYN Earnings vs Peers
Earnings metrics vs comparable public companies
DYN Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$446M | -40.6% | -$468M | $-3.47 | - | - |
| 2024 | -$317M | -34.5% | -$344M | $-3.37 | - | - |
| 2023 | -$236M | -40.4% | -$242M | $-3.95 | - | - |
| 2022 | -$168M | -12.6% | -$171M | $-3.23 | - | - |
| 2021 | -$149M | -154.2% | -$150M | $-2.93 | - | - |
| 2020 | -$59M | -333.9% | -$59M | $-1.24 | - | - |
| 2019 | -$14M | -181.4% | -$14M | $-0.30 | - | - |
| 2018 | -$5M | -106.3% | -$5M | $-0.47 | - | - |
| 2017 | $76M | +106.1% | -$412M | $0.47 | 15.0% | -81.4% |
| 2016 | -$1.24B | -2580.0% | -$640M | $-9.61 | -90.8% | -46.9% |
| 2015 | $50M | +174.6% | $64M | $0.40 | 5.9% | 7.6% |
| 2014 | -$67M | +81.2% | -$318M | $-0.53 | -4.6% | -21.7% |
| 2013 | -$356M | -509.2% | -$318M | $-3.56 | -11866.7% | -10600.0% |
| 2012 | $87M | +105.3% | $714M | $0.87 | 2900.0% | 23800.0% |
| 2011 | -$1.65B | -603.0% | -$236M | $-13.48 | -103.8% | -14.9% |
| 2010 | -$234M | +81.5% | -$11M | $-1.93 | -10.1% | -0.5% |
| 2009 | -$1.26B | -825.3% | -$834M | $-1.25 | -51.1% | -33.8% |
| 2008 | $174M | -34.1% | $709M | $0.20 | 4.9% | 20.0% |
| 2007 | $264M | - | $605M | $0.25 | 8.5% | 19.5% |
Download Data
Export DYN earnings history in CSV or JSON format
Free sign-in required to download data
DYN Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DYN — Frequently Asked Questions
Quick answers to the most common questions about buying DYN stock.
What is DYN earnings per share (EPS)?
DYN trailing twelve-month (TTM) diluted EPS is $-3.33, reflecting -3.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2007 to 2025 is available in the table on this page.
What is Dyne Therapeutics, Inc.'s net income?
Dyne Therapeutics, Inc. (DYN) trailing twelve-month net income is $-605M as of 2025. Earnings declined -3.0% year-over-year.
Is DYN profitable?
DYN is not currently profitable on a TTM basis, reporting a net loss of $-605M. Net margin is N/A. Investors should monitor for a return to profitability.
What is DYN's earnings growth rate?
DYN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.
What are DYN's profit margins?
Dyne Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.7%.
Is DYN growing earnings?
DYN earnings growth is slowing. Current YoY EPS growth of -3.0% trails the 5-year CAGR of N/A. TTM net income is $-605M.
What was DYN's best earnings year?
Dyne Therapeutics, Inc.'s highest annual net income on record is $264M, achieved in fiscal year 2007. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.
What were DYN's earnings last quarter?
DYN's most recent reported quarter was Q3 2026. Net income was $-194M with diluted EPS of $-1.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.